CV
CapsoVision, IncCompany with tickers: CV
CIK
1378325
CUSIP
140935107
Shares Outstanding
49,838,211
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-19 | Tsai Chen Lung | Director | Award | 4,045 |
| 2026-03-19 | Imperial Joanne Carol | Director | Award | 4,045 |
| 2026-03-19 | Harari Michele | Director | Award | 4,045 |
| 2026-03-19 | GOUW JULIA S | Director | Award | 4,045 |
| 2026-03-19 | Kuo Hui Ying | Director | Award | 4,045 |
| 2026-03-19 | King Wen-Herng Henry | Director | Award | 4,045 |
| 2026-03-17 | Shen Ching Hang | 10% Owner | Other | 4,352,606 |
| 2026-03-16 | HARARI ELIYAHOU ET AL | 10% Owner | Other | 878,448 |
| 2025-12-31 | Harari Michele | Director | Convert | 2,887 |
| 2025-12-31 | Harari Michele | Director | Convert | 2,887 |
| 2025-12-31 | GOUW JULIA S | Director | Convert | 2,887 |
| 2025-12-31 | GOUW JULIA S | Director | Convert | 2,887 |
| 2025-12-31 | Imperial Joanne Carol | Director | Convert | 2,887 |
| 2025-12-31 | Imperial Joanne Carol | Director | Convert | 2,887 |
| 2025-12-31 | King Wen-Herng Henry | Director | Convert | 2,887 |
| 2025-12-31 | King Wen-Herng Henry | Director | Convert | 2,887 |
| 2025-12-31 | Kuo Hui Ying | Director | Convert | 2,887 |
| 2025-12-31 | Kuo Hui Ying | Director | Convert | 2,887 |
| 2025-12-31 | Tsai Chen Lung | Director | Convert | 2,887 |
| 2025-12-31 | Tsai Chen Lung | Director | Convert | 2,887 |
| 2025-11-03 | Garcia David Michael | Sr. VP of Finance | Award | 165,000 |
| 2025-11-03 | Garcia David Michael | Sr. VP of Finance | Other | 0 |
| 2025-09-15 | Tsai Chen Lung | Director | Award | 2,887 |
| 2025-09-15 | Kuo Hui Ying | Director | Award | 2,887 |
| 2025-09-15 | King Wen-Herng Henry | Director | Award | 2,887 |
| 2025-09-15 | Imperial Joanne Carol | Director | Award | 2,887 |
| 2025-09-15 | GOUW JULIA S | Director | Award | 2,887 |
| 2025-09-15 | Harari Michele | Director | Award | 2,887 |
| 2025-09-15 | Harari Michele | Director | Other | 56,156 |
| 2025-08-18 | Petersen Rebecca Ann | Director of Clinical Affairs | Convert | 24,834 |
| 2025-08-18 | Petersen Rebecca Ann | Director of Clinical Affairs | Convert | 7,507 |
| 2025-07-03 | HARARI ELIYAHOU ET AL | 10% Owner | Other | 1,206,898 |
| 2025-07-03 | HARARI ELIYAHOU ET AL | 10% Owner | Other | 2,000,000 |
| 2025-07-03 | HARARI ELIYAHOU ET AL | 10% Owner | Other | 434,783 |
| 2025-07-03 | HARARI ELIYAHOU ET AL | 10% Owner | Other | 434,782 |
| 2025-07-03 | HARARI ELIYAHOU ET AL | 10% Owner | Other | 3,186,904 |
| 2025-07-03 | HARARI ELIYAHOU ET AL | 10% Owner | Other | 934,588 |
| 2025-07-03 | HARARI ELIYAHOU ET AL | 10% Owner | Other | 222,222 |
| 2025-07-03 | HARARI ELIYAHOU ET AL | 10% Owner | Other | 4,638,377 |
| 2025-07-03 | HARARI ELIYAHOU ET AL | 10% Owner | Other | 740,741 |
| 2025-07-03 | King Wen-Herng Henry | Director | Other | 20,710 |
| 2025-07-03 | King Wen-Herng Henry | Director | Other | 68,966 |
| 2025-07-03 | Wang Kang-Huai | Director, See Remarks | Other | 33,707 |
| 2025-07-03 | Wang Kang-Huai | Director, See Remarks | Other | 446,896 |
| 2025-07-03 | Wang Kang-Huai | Director, See Remarks | Other | 1,407,407 |
| 2025-07-03 | Wang Kang-Huai | Director, See Remarks | Other | 35,947 |
| 2025-07-03 | Wang Kang-Huai | Director, See Remarks | Other | 11,111 |
| 2025-07-03 | Kuo Hui Ying | Director | Other | 10,354 |
| 2025-07-03 | Kuo Hui Ying | Director | Other | 34,482 |
| 2025-07-03 | Tsai Chen Lung | Director | Other | 86,956 |
| 2025-07-03 | Tsai Chen Lung | Director | Other | 90,534 |
| 2025-07-03 | Tsai Chen Lung | Director | Other | 91,432 |
| 2025-07-03 | Tsai Chen Lung | Director | Other | 71,429 |
| 2025-07-03 | Tsai Chen Lung | Director | Other | 55,555 |
| 2025-07-01 | Lundquist Kevin Michael | Chief Financial Officer | Other | 0 |
| 2025-07-01 | Wang Kang-Huai | Director, See Remarks | Other | 0 |
| 2025-07-01 | Wang Kang-Huai | Director, See Remarks | Other | 0 |
| 2025-07-01 | Wang Kang-Huai | Director, See Remarks | Other | 915,207 |
| 2025-07-01 | Wang Kang-Huai | Director, See Remarks | Other | 0 |
| 2025-07-01 | Wang Kang-Huai | Director, See Remarks | Other | 0 |
| 2025-07-01 | Wang Kang-Huai | Director, See Remarks | Other | 0 |
| 2025-07-01 | GOUW JULIA S | Director | Other | 0 |
| 2025-07-01 | HARARI ELIYAHOU ET AL | 10% Owner | Other | 0 |
| 2025-07-01 | HARARI ELIYAHOU ET AL | 10% Owner | Other | 0 |
| 2025-07-01 | HARARI ELIYAHOU ET AL | 10% Owner | Other | 280,000 |
| 2025-07-01 | HARARI ELIYAHOU ET AL | 10% Owner | Other | 0 |
| 2025-07-01 | HARARI ELIYAHOU ET AL | 10% Owner | Other | 0 |
| 2025-07-01 | HARARI ELIYAHOU ET AL | 10% Owner | Other | 0 |
| 2025-07-01 | HARARI ELIYAHOU ET AL | 10% Owner | Other | 0 |
| 2025-07-01 | HARARI ELIYAHOU ET AL | 10% Owner | Other | 0 |
| 2025-07-01 | HARARI ELIYAHOU ET AL | 10% Owner | Other | 0 |
| 2025-07-01 | King Wen-Herng Henry | Director | Other | 0 |
| 2025-07-01 | Petersen Rebecca Ann | Director of Clinical Affairs | Other | 0 |
| 2025-07-01 | Imperial Joanne Carol | Director | Other | 0 |
| 2025-07-01 | Harari Michele | Director | Other | 187,000 |
| 2025-07-01 | Kuo Hui Ying | Director | Other | 0 |
| 2025-07-01 | Atkinson Douglas Patrick | Head of Global Sales | Other | 0 |
| 2025-07-01 | Tsai Chen Lung | Director | Other | 80,000 |
| 2025-07-01 | Tsai Chen Lung | Director | Other | 0 |
| 2025-07-01 | Tsai Chen Lung | Director | Other | 0 |
| 2025-07-01 | Tsai Chen Lung | Director | Other | 0 |
| 2025-07-01 | Tsai Chen Lung | Director | Other | 0 |